Care Health Insurance Ltd
Standalone health insurer riding India's under-penetrated retail health cover market.
Market cap
₹15,196 Cr
104.80 Cr shares
P/E ratio
16.53
Sector average 46
Book value
₹40.34
P/B 3.59
1-year return
-9.95%
52w ₹145 – ₹238
Currently 0% of the way through its 52-week range.
Indicative price history
1Y change
-9.22% ₹160 → ₹145
52-week band in this window: ₹145.00 – ₹225.27. Weekly indicative marks, not exchange-traded prices.
Key highlights
- Among the fastest-growing standalone health insurers with retail health above 60% of premium.
- Gross written premium compounding near 20% a year with a stable combined ratio.
- Majority owned by a listed financial services group; a large private bank is a strategic holder.
About Care Health
Care Health Insurance is a standalone health insurance company offering retail indemnity plans, group health cover, top-up policies, travel insurance and personal accident products.
Distribution runs through individual agents, banca partnerships, brokers and a direct digital channel, with a large in-house claims and network hospital operation.
The company is majority owned by a listed financial services group and counts a large private bank among its shareholders.
Where the revenue comes from
- Retail health63%
Individual and family floater indemnity plans
- Group health24%
Corporate employee benefit cover
- Travel & personal accident8%
Short-tenure specialty products
- Investment income5%
Float deployed in fixed income and equities
Products & services
Care Supreme / Care Plus
Retail indemnity health cover for individuals and families.
Group health
Employer-sponsored cover for corporates and SMEs.
Care Freedom / Senior
Products for older lives and pre-existing conditions.
Travel & personal accident
Short-tenure specialty covers.
What works
- • Retail health insurance in India remains structurally under-penetrated with long runway for premium growth.
- • Renewal-heavy retail book produces sticky, recurring premium income.
- • Standalone health licence allows deeper product specialisation than multi-line general insurers.
What to watch
- • Medical inflation can outpace repricing and push the claims ratio higher.
- • Aggressive competition on pricing in group health can dilute underwriting profit.
- • Regulatory changes on commissions, pricing or portability affect economics directly.
Compare with peers
| Company | Price | Market cap | P/E | P/B | Rev CAGR |
|---|---|---|---|---|---|
| Care HealthThis page | ₹145.00 | ₹15,196 Cr | 16.53 | 3.59 | +20.87% |
| Hero FinCorp | ₹980.00 | ₹12,642 Cr | 9.52 | 1.35 | +15.82% |
| Orbis Financial | ₹338.00 | ₹4,597 Cr | 20.61 | 4.62 | +28.12% |
Latest reported year: FY26 ending 31 Mar 2026.